Castle Biosciences (CSTL) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Castle Biosciences (CSTL) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 20, 2024 (04:06)

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

Latest session on the 19th of July for
Castle Biosciences, Inc. is positive
Trading Volume: 418421
Open: 18.87 /  High: 20.23 /  Low: 18.7
What analysts predict: $34.33
52-week High/Low: $25.91 / $12.07

50/200 Day Moving Average: $22.1 / $20.77

This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.

For Castle Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Castle Biosciences share be worth in 2024 - 2028?

When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock? We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.


Historical and forecast chart of Castle Biosciences stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 22 20.51 20.26 20.80 2.67
Jul 23 20.72 20.07 20.91 4.17
Jul 24 20.25 19.91 20.60 3.46
Jul 25 19.92 19.68 20.30 3.12
Jul 26 19.61 19.32 20.02 3.61
Jul 27 20.29 19.68 20.56 4.50
Jul 28 20.38 20.21 20.71 2.46
Jul 29 20.47 19.94 21.08 5.71
Jul 30 19.82 19.37 20.02 3.40
Jul 31 19.09 18.85 19.37 2.75
Aug 01 19.37 19.03 19.97 4.97
Aug 02 19.25 19.06 19.84 4.08
Aug 03 19.31 18.95 19.49 2.85
Aug 04 19.34 18.96 19.90 4.98
Aug 05 19.73 19.09 20.17 5.62
Aug 06 20.47 20.16 20.75 2.92
Aug 07 20.17 19.79 20.56 3.87
Aug 08 20.87 20.67 21.13 2.18
Aug 09 20.64 20.19 21.18 4.91
Aug 10 20.39 20.21 20.89 3.39
Aug 11 20.70 20.54 21.31 3.75
Aug 12 20.14 19.54 20.57 5.28
Aug 13 19.77 19.33 20.20 4.46
Aug 14 20.52 20.13 20.91 3.87
Aug 15 21.19 20.62 21.45 4.03
Aug 16 20.90 20.56 21.40 4.06
Aug 17 20.30 19.85 20.77 4.66
Aug 18 19.81 19.63 20.35 3.63
Aug 19 20.09 19.66 20.52 4.37
Aug 20 19.39 19.23 20.00 3.99

Castle Biosciences Daily Price Targets


Castle Biosciences Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $20.51.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 2.603%.
Pessimistic target level: 20.26
Optimistic target level: 20.80

Castle Biosciences Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $20.72.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.003%.
Pessimistic target level: 20.07
Optimistic target level: 20.91

Castle Biosciences Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $20.25.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.341%.
Pessimistic target level: 19.91
Optimistic target level: 20.60

Castle Biosciences Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $19.92.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.023%.
Pessimistic target level: 19.68
Optimistic target level: 20.30

Castle Biosciences Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $19.61.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.487%.
Pessimistic target level: 19.32
Optimistic target level: 20.02

Castle Biosciences Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $20.29.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.302%.
Pessimistic target level: 19.68
Optimistic target level: 20.56

CSTL (CSTL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 20.40 19.68 22.05 10.75
Sep. 21.11 20.31 23.48 13.47
Oct. 22.35 20.73 24.33 14.79
Nov. 21.57 19.52 23.81 18.01
Dec. 21.78 20.72 23.31 11.12

Castle Biosciences forecast for this year


Castle Biosciences Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $20.3984. Pessimistic: $19.68. Optimistic: $22.05


Castle Biosciences Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $21.1123. Pessimistic: $20.31. Optimistic: $23.48


Castle Biosciences Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $22.3537. Pessimistic: $20.73. Optimistic: $24.33


Castle Biosciences Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $21.5713. Pessimistic: $19.52. Optimistic: $23.81


Castle Biosciences Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $21.7827. Pessimistic: $20.72. Optimistic: $23.31



Castle Biosciences (CSTL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 24.07 23.26 25.38 8.36
Feb 26.90 25.09 28.03 10.48
Mar 28.60 25.79 29.56 12.73
Apr 30.16 29.10 32.56 10.63
May 30.79 28.55 32.38 11.85
Jun 32.04 29.39 35.27 16.66
Jul 30.60 27.56 33.60 17.98
Aug 30.18 27.39 31.40 12.78
Sep 28.61 27.73 31.46 11.84
Oct 31.02 29.84 33.14 9.96
Nov 29.06 26.99 29.92 9.79
Dec 30.12 27.17 31.89 14.81

Castle Biosciences (CSTL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 28.14 26.96 30.74 12.30
Feb 29.71 26.97 31.92 15.51
Mar 31.21 28.42 34.36 17.30
Apr 29.33 28.47 32.13 11.38
May 29.09 27.66 30.96 10.65
Jun 25.38 24.17 27.55 12.25
Jul 28.61 27.05 29.78 9.15
Aug 29.22 27.17 31.55 13.87
Sep 29.01 26.13 30.68 14.83
Oct 32.99 30.22 34.47 12.33
Nov 33.59 30.44 34.63 12.09
Dec 33.12 30.71 34.74 11.61

Castle Biosciences (CSTL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 30.52 27.83 33.09 15.89
Feb 27.92 25.92 30.42 14.78
Mar 30.89 28.68 33.22 13.67
Apr 30.46 27.94 33.10 15.59
May 32.63 29.84 33.77 11.63
Jun 32.45 31.08 35.17 11.62
Jul 34.45 32.18 36.42 11.65
Aug 37.58 35.37 40.26 12.15
Sep 40.32 38.17 44.83 14.86
Oct 40.71 38.32 44.87 14.61
Nov 38.94 35.89 42.27 15.09
Dec 36.49 34.91 38.94 10.36

Castle Biosciences (CSTL) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 37.21 35.23 40.80 13.66
Feb 34.60 33.10 36.01 8.07
Mar 35.62 34.57 38.76 10.81
Apr 39.26 35.52 40.85 13.05
May 37.23 34.93 39.68 11.95
Jun 38.27 36.13 39.82 9.28
Jul 36.13 32.18 37.34 13.82
Aug 34.46 32.91 36.58 10.02
Sep 35.66 34.21 38.31 10.69
Oct 35.71 32.41 37.46 13.48
Nov 36.46 34.73 39.01 10.99
Dec 37.89 33.65 40.76 17.44

Castle Biosciences information and performance

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 522 880 000 $

Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.

EBITDA: -29 148 000 $

EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.13

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926
Quarterly Revenue Growth YOY: 0.736
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.482

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.23

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 27607200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.